Verimmune

VerImmune is a biotechnology company specializing in cancer therapy. It develops a new method called Anti-tumor Immune Redirection, a strategy that utilizes a proprietary virus-inspired particle (ViP) technology platform that redirects pre-existing pathogenic or childhood vaccine immune memory towards tumors.